Matches in Wikidata for { <http://www.wikidata.org/entity/Q92759694> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- Q92759694 description "article scientifique publié en 2020" @default.
- Q92759694 description "articolo scientifico (pubblicato il 2020)" @default.
- Q92759694 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q92759694 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92759694 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92759694 description "scientific article published on 01 January 2020" @default.
- Q92759694 description "wetenschappelijk artikel" @default.
- Q92759694 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q92759694 description "научна статия" @default.
- Q92759694 name "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 name "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 name "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 type Item @default.
- Q92759694 label "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 label "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 label "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 prefLabel "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 prefLabel "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 prefLabel "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 P1433 Q92759694-7D54334E-19AA-40E4-AD3B-7A3168447D1E @default.
- Q92759694 P1476 Q92759694-B744BBBC-C4BB-4DDF-A1D7-831889C9B1D1 @default.
- Q92759694 P2093 Q92759694-0069A1FC-FD67-487B-B2F4-9F67596F73A1 @default.
- Q92759694 P2093 Q92759694-23BF3CDE-83B1-4CB8-A71E-9F7B0CE84E0F @default.
- Q92759694 P2093 Q92759694-3CC69F14-FB8E-430C-B3D1-DA1262A6FACF @default.
- Q92759694 P2093 Q92759694-57C2A250-468E-4F31-BE02-0309261DD089 @default.
- Q92759694 P2093 Q92759694-96B5AE97-923C-484B-93D4-B1F68DC96EE2 @default.
- Q92759694 P2093 Q92759694-C3E6B7C6-0B8D-44EE-8497-6B7A6661F8AF @default.
- Q92759694 P2093 Q92759694-DA7E64F8-E232-4587-9400-67E3FDB43ED8 @default.
- Q92759694 P2093 Q92759694-DD7295D9-66D4-4CC9-AE8E-C1362BE47551 @default.
- Q92759694 P275 Q92759694-90f985fc-6c13-47ae-8d65-7d5f94e8f231 @default.
- Q92759694 P2860 Q92759694-0318A99A-CB0A-44E8-B3E1-C049199D817E @default.
- Q92759694 P2860 Q92759694-3E96E87C-8B1A-44F8-A1A1-0E91660E243B @default.
- Q92759694 P2860 Q92759694-417C1E43-E39B-422C-A0AC-5620D3BC6700 @default.
- Q92759694 P2860 Q92759694-4B8F9879-1904-4849-8BEF-5A216818E1DC @default.
- Q92759694 P2860 Q92759694-568DF4F8-64B5-43E1-8191-B9EE93911273 @default.
- Q92759694 P2860 Q92759694-5841692F-FD50-4589-91DA-61B73AD0ABCE @default.
- Q92759694 P2860 Q92759694-58736A52-8991-4EA0-845B-43969E3135DA @default.
- Q92759694 P2860 Q92759694-7220FF1B-325C-4EB9-A372-FBED7B840E01 @default.
- Q92759694 P2860 Q92759694-8704911D-7441-49B5-B281-53567947F2D8 @default.
- Q92759694 P2860 Q92759694-9114B2C2-0C98-4D9F-8C4B-FCDDBABDAF50 @default.
- Q92759694 P2860 Q92759694-ACBBAC44-461F-4BB0-9E90-965C339AFA7E @default.
- Q92759694 P2860 Q92759694-B1316E6C-1FD9-49C5-9107-7676818DA6CF @default.
- Q92759694 P2860 Q92759694-EDE052FC-CC55-45DC-B3BD-BD9F84B90CAA @default.
- Q92759694 P304 Q92759694-A6047F3D-DD98-4275-A93B-124FF8F646F7 @default.
- Q92759694 P31 Q92759694-965547AB-AA4B-475F-B78E-154BDE459469 @default.
- Q92759694 P356 Q92759694-D3FC4C2D-0C10-47EA-8056-20609D3D9BF8 @default.
- Q92759694 P433 Q92759694-5882ABD8-D72D-461F-93CA-E59DAA138819 @default.
- Q92759694 P478 Q92759694-3610988A-7286-4B10-BA2D-BC82581F8CF2 @default.
- Q92759694 P577 Q92759694-A54F3832-9183-44D5-B4FC-1F770562CA27 @default.
- Q92759694 P6216 Q92759694-bf559bc9-6b06-4e6d-8cac-169bdf41c9a1 @default.
- Q92759694 P698 Q92759694-ECBE2390-4A42-47E7-B6D5-8EA19517E09A @default.
- Q92759694 P932 Q92759694-6742C711-2AC8-4AAC-A578-E76CBA8D37BD @default.
- Q92759694 P356 SAJC.SAJC_433_18 @default.
- Q92759694 P698 31956615 @default.
- Q92759694 P1433 Q26842041 @default.
- Q92759694 P1476 "A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer" @default.
- Q92759694 P2093 "Amit Joshi" @default.
- Q92759694 P2093 "Archi Agarwal" @default.
- Q92759694 P2093 "Atanu Bhattacharjee" @default.
- Q92759694 P2093 "Kumar Prabhash" @default.
- Q92759694 P2093 "Nilesh Sable" @default.
- Q92759694 P2093 "Palak Popat" @default.
- Q92759694 P2093 "Sameer Shrirangwar" @default.
- Q92759694 P2093 "Vanita Noronha" @default.
- Q92759694 P275 Q24082749 @default.
- Q92759694 P2860 Q24612084 @default.
- Q92759694 P2860 Q29616218 @default.
- Q92759694 P2860 Q29617512 @default.
- Q92759694 P2860 Q33235187 @default.
- Q92759694 P2860 Q33566395 @default.
- Q92759694 P2860 Q34129127 @default.
- Q92759694 P2860 Q34778772 @default.
- Q92759694 P2860 Q35083279 @default.
- Q92759694 P2860 Q36309725 @default.
- Q92759694 P2860 Q36778558 @default.
- Q92759694 P2860 Q36876865 @default.
- Q92759694 P2860 Q38169849 @default.
- Q92759694 P2860 Q39922512 @default.
- Q92759694 P304 "23-26" @default.
- Q92759694 P31 Q13442814 @default.
- Q92759694 P356 "10.4103/SAJC.SAJC_433_18" @default.
- Q92759694 P433 "1" @default.
- Q92759694 P478 "9" @default.
- Q92759694 P577 "2020-01-01T00:00:00Z" @default.
- Q92759694 P6216 Q50423863 @default.
- Q92759694 P698 "31956615" @default.
- Q92759694 P932 "6956584" @default.